-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Revenues history and growth rate from 2010 to 2017.
- Ionis Pharmaceuticals Inc Revenues for the quarter ending December 31, 2023 was $325M, a 114% increase year-over-year.
- Ionis Pharmaceuticals Inc annual Revenues for 2017 was $508M, a 46.5% increase from 2016.
- Ionis Pharmaceuticals Inc annual Revenues for 2016 was $347M, a 22.2% increase from 2015.
- Ionis Pharmaceuticals Inc annual Revenues for 2015 was $284M, a 32.5% increase from 2014.